Policy Updates
Check insights and updates from APIC!
The first case of clade I mpox in the U.S. was confirmed by the California Department of Public Health. The patient had recently traveled from a region in Africa where the strain is circulating. The person isolated at home and there is no evidence that mpox clade I is spreading in the U.S. Read more.
The FDA announced that Baxter Healthcare Corporation issued an Urgent Medical Device Recall of certain lots of Solution Sets with Duo-Vent Spikes due to incorrect assembly with inverted side clamps. An inverted side clamp may not allow medication to be delivered, and the patient’s blood may backflow into the set and source container. Read more.
The Administration for Strategic Preparedness and Response (ASPR) released the U.S. DHHS All-Hazards Plan, HHS’s emergency operations framework for coordinated departmental response and recovery from disasters and public health emergencies. It provides an all-discipline all-hazards approach to coordinated federal public health, medical, human services, and social services assistance to support state and local governments’ activities … Continued
APIC provided comments to Leapfrog in response to its proposed updates to the 2025 Leapfrog Hospital Survey. APIC’s recommendations included adding subsections on infection preventionist staffing (Section 5) and patient bathing (Section 6) and reducing the number of required hand hygiene observations (Section 6C). Read APIC’s comments.
The NHSN team has scheduled training webinars on the new 2022 Rebaseline reports. Register here for the Wednesday, December 18 1-2 pm ET webinar on SSI reports. Register here for the Thursday, December 19 2-3 pm ET webinar on MRSA LabID events. Webinars will also be recorded and posted to the NHSN Rebaseline Education webpage.
CMS has issued revised guidance on Appendix Q which indicates when an immediate jeopardy citation is warranted. The full outline and memo can be found here.
CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) met November 14-15, 2024 to discuss updates to the Infection Control in Healthcare Personnel Guideline and the Part 1 Draft update to the Isolation Precautions Guideline. The committee approved draft recommendations to the Viral Respiratory Infections section of the IC in HCP Guideline, which will now go … Continued
The CDC is asking NHSN users to reply to a questionnaire to assess the potential impact on hospitals due to the disruption to the supply of BD BACTECTM blood culture media bottles between June and October 2024. The questionnaire will be available from December 14 – 31, 2024 in the December NHSN newsletter.
The FDA issued “Transitional Enforcement Policy for Ethylene Oxide (EtO) Sterilization Facility Changes for Class III Devices” to respond to anticipated changes in EtO sterilization activities as facilities work to advance orderly implementation of and compliance with EPA’s 2024 rule which revised emissions standards for EtO. This guidance is intended to prevent or mitigate the … Continued